IceCure Medical (ICCM) Depreciation & Amortization (CF) (2025 - 2026)

IceCure Medical (ICCM) reported Depreciation & Amortization (CF) of $69000.0 for Q1 2026, down 22.47% year-over-year from $89000.0 in Q1 2025, and down 22.47% on a QoQ basis from $89000.0 in Q1 2025.

IceCure Medical (ICCM) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $69000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 22.47% year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158000.0 (up 77.53% YoY) and the FY2025 annual result came in at $295000.0, down 11.14% from the prior year.
  • Depreciation & Amortization (CF) fell to $69000.0 in Q1 2026 per ICCM's latest filing, from $89000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $89000.0 in Q1 2025 and bottomed at $69000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 749.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 67.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.40 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 69,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69,000.00
Mar 31, 2026 69,000.00
Mar 31, 2025 89,000.00
Mar 31, 2025 89,000.00